In this podcast, Jeffrey Tabas, MD, talks about his session at the American College of Emergency Physicians 2021, which focused on the challenges of diagnosing and managing atrial fibrillation in the emergency department. Find out more about his session and register for sessions here.
For more parts of this series, visit our resource center for the American College of Emergency Physicians 2021 Scientific Assembly.
Additional Resource:
- Tabas J. Atrial fibrillation 2021: don’t miss a beat. Talk presented at: American College of Emergency Physicians 2021; October 25-28, 2021; Boston, Massachusetts. https://cdn.base.parameter1.com/files/base/ascend/hh/document/2021/10/ACEP21_DigitalProgram.616f40ccac5fc.pdf
Jeffrey Tabas, MD, is a professor of emergency medicine at the University of California, San Francisco’s School of Medicine, an emergency medicine physician at Zuckerberg’s San Francisco General Emergency Department, the director of faculty development for the Department of Emergency Medicine, and the director of Outcomes and Innovations for the UCSF Office of Continuing Medical Education.
TRANSCRIPTION:
Amanda Balbi: Hello and welcome to a special series of Podcasts360. I’m your moderator, Amanda Balbi. In this 6-part series, we will be speaking with Dr Jeffrey Tabas, who is a professor of emergency medicine at the University of California, San Francisco’s School of Medicine, an emergency medicine physician at Zuckerberg’s San Francisco General Emergency Department, the director of faculty development for the Department of Emergency Medicine, and the director of Outcomes and Innovations for the UCSF Office of Continuing Medical Education.
He recently presenting a session on atrial fibrillation at the American College of Emergency Physicians 2021 Scientific Assembly. In part 1 of this series, he gives us a preview of his session and what attendees should expect.
Let’s listen in as he answers our questions.
To begin, can you give us a preview of your session at ACEP 2021?
Jeffrey Tabas: Sure, I'm speaking about updates in the emergency management of atrial fibrillation in 2021. It's at our Boston Scientific Assembly upcoming at the end of October. I focus on 3 main areas that provide challenges in the emergency management of atrial fibrillation. One is how to rate control and what are some of the pitfalls in controlling someone who presents with a fast rate, (2) the role of anticoagulation and a simple way to think about who should get anticoagulated, and then (3) ED cardioversion and the benefits in doing so in the emergency department.
Amanda Balbi: Thank you so much for speaking with me today. And for our listeners, stay tuned for the subsequent parts of this series.
